HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): John R. Doty Donald B. Doty Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Doty, J. R. Articles by Doty, D. B. Search for Related Content PubMed PubMed Citation Articles by Doty, J. R. Articles by Doty, D. B.

Ann Thorac Surg 1999;67:1111-1116
© 1999 The Society of Thoracic Surgeons

---

Original Articles

Superior vena cava obstruction: bypass using spiral vein graft

^a Department of Surgery, LDS Hospital, Salt Lake City, Utah, USA

Accepted for publication December 17, 1998.

Address reprint requests to Dr Donald Doty, 324 Tenth Ave, Salt Lake City, UT 84103
e-mail: ldddoty{at}ihc.com

Background. Previous midterm experience with the composite spiral saphenous vein graft to bypass the obstructed superior vena cava (SVC) has been favorable. This study looks at the long-term results in patients followed for up to 23 years.

Methods. Sixteen patients aged 17 to 68 years had operation for obstruction of the SVC with SVC syndrome caused by benign disease. Eleven patients had fibrosing mediastinitis with or without caseous necrosis, 4 had thrombosis caused by a catheter or a pacemaker electrode, and 1 had spontaneous thrombosis. All operations were performed using a composite spiral vein graft constructed from the patient’s own saphenous vein. Graft diameter ranged from 9.5 to 15.0 mm. Ten grafts were from the left innominate vein, and six grafts were from the right or left internal jugular vein. The grafts were placed to the right atrial appendage in all patients except 1. Follow-up extends from 1 month to 23 years 8 months (mean follow-up, 10.9 years).

Results. Fourteen of 16 grafts remain patent for up to 23 years, and all patients but 1 are free from SVC syndrome. One patient required revision of the graft for thrombosis 4 days after operation. Two grafts closed during the first year after operation: one because of recurrence of spontaneous venous thrombosis and the other because of aggressive fibrosing mediastinitis requiring operation for graft revision three times over a 12-year period prior to death.

Conclusions. These data demonstrate that a spiral vein bypass graft for treatment of the obstructed SVC relieves SVC syndrome and has excellent long-term patency.

This article has been cited by other articles:

				M. L. Brown, A. R. Cedeno, E. S. Edell, D. J. Hagler, and H. V. Schaff Operative strategies for pulmonary artery occlusion secondary to mediastinal fibrosis. Ann. Thorac. Surg., July 1, 2009; 88(1): 233 - 237. [Abstract] [Full Text] [PDF]

				R. L. Hannan, J. A. Zabinsky, A. Hernandez, E. M. Zahn, and R. P. Burke Hybrid treatment of superior vena cava syndrome in a child. Ann. Thorac. Surg., July 1, 2009; 88(1): 277 - 278. [Abstract] [Full Text] [PDF]

				A. A. Amirghofran, A. Emaminia, S. Rayatpisheh, S. A. Malek-Hosseini, and Y. Attaran Intracardiac invasive thymoma presenting as superior vena cava syndrome. Ann. Thorac. Surg., May 1, 2009; 87(5): 1616 - 1618. [Abstract] [Full Text] [PDF]

				E. Pompeo, F. Stella, A. Ippoliti, and T. C. Mineo Extra-anatomic bypass of the superior vena cava after successful stenting for fibrosing mediastinitis J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 220 - 221. [Full Text] [PDF]

				W. D. Lu, F. L. Yu, and Z. S. Wu Superior vena cava reconstruction using bovine jugular vein conduit Eur. J. Cardiothorac. Surg., November 1, 2007; 32(5): 816 - 817. [Abstract] [Full Text] [PDF]

				G. Xu, C. Alexiou, M. Tofeig, and T. J. Spyt Management of superior vena cava obstruction syndrome due to thrombosis of a Contegra conduit used to re-establish the innominate vein-to-right atrium continuity Interactive CardioVascular and Thoracic Surgery, August 1, 2007; 6(4): 517 - 518. [Abstract] [Full Text] [PDF]

				H. Ruge, S. M. Wildhirt, M. Poerner, N. Mayr, R. Bauernschmitt, S. Martinoff, and R. Lange Severe Superior Vena Cava Syndrome after Transvenous Pacemaker Implantation Ann. Thorac. Surg., December 1, 2006; 82(6): e41 - e42. [Abstract] [Full Text] [PDF]

				S. Bays, C. Rajakaruna, E. Sheffield, and A. Morgan Fibrosing mediastinitis as a cause of superior vena cava syndrome Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 453 - 455. [Abstract] [Full Text] [PDF]

				A. Kostopoulou, E. Sbarouni, E. G. Livanis, G. N. Theodorakis, and D. Kremastinos Superior vena cava syndrome and syncope in an implantable cardioverter defibrillator recipient Europace, January 1, 2004; 6(3): 205 - 208. [Abstract] [Full Text] [PDF]

				S. M. Caples and J. Utz Successful Surgical Treatment of Recurrent Pleural Effusions From SVC Syndrome Related to Mediastinal Fibrosis Diagnosed 24 Years Earlier Chest Meeting Abstracts, October 1, 2003; 124(4): 273S - 274. [Abstract] [Full Text] [PDF]

				S. E. Rossi, H. P. McAdams, M. L. Rosado-de-Christenson, T. J. Franks, and J. R. Galvin Fibrosing Mediastinitis RadioGraphics, May 1, 2001; 21(3): 737 - 757. [Abstract] [Full Text] [PDF]